2.8820
-0.2660
(-8.45%)
As of 1:05:10 PM GMT+2. Market Open.
Loading Chart for T0A.SG
- Previous Close
3.1480 - Open
2.8840 - Bid 2.8840 x --
- Ask 3.0140 x --
- Day's Range
2.8820 - 2.8840 - 52 Week Range
2.8320 - 13.2800 - Volume
0 - Avg. Volume
1,474 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 7, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: T0A.SG
View MorePerformance Overview: T0A.SG
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
T0A.SG
35.87%
S&P/TSX Composite index (^GSPTSE)
6.52%
1-Year Return
T0A.SG
73.12%
S&P/TSX Composite index (^GSPTSE)
4.09%
3-Year Return
T0A.SG
83.84%
S&P/TSX Composite index (^GSPTSE)
5.62%
5-Year Return
T0A.SG
87.65%
S&P/TSX Composite index (^GSPTSE)
62.46%
Compare To: T0A.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
2.8820
-8.45%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
4.1100
-3.52%
Mkt Cap 225.574M
Industry Drug Manufacturers—Specialty & Generic
0.5054
-4.66%
Mkt Cap 503.821M
Industry Drug Manufacturers—Specialty & Generic
Statistics: T0A.SG
View MoreValuation Measures
As of 4/10/2025
Market Cap
572.57M
Enterprise Value
1.05B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.55
Price/Book (mrq)
0.52
Enterprise Value/Revenue
0.97
Enterprise Value/EBITDA
4.07
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--